SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-034853
Filing Date
2015-05-06
Accepted
2015-05-06 16:02:19
Documents
3
Period of Report
2015-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-10484_18k.htm 8-K 24737
2 EX-99.1 a15-10484_1ex99d1.htm EX-99.1 91050
3 GRAPHIC g104841mmi001.jpg GRAPHIC 4739
  Complete submission text file 0001104659-15-034853.txt   123613
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 15836891
SIC: 2834 Pharmaceutical Preparations